|
業務類別
|
Biotechnology |
|
業務概覽
|
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program ofthe company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205). |
| 公司地址
| 5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 267-4467 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.artivabio.com |
| 員工數量
| 89 |
| Dr. Heather Raymon, PhD |
Senior Vice President, Research and Early Development |
-- |
29/04/2025 |
| Dr. Fred Aslan, M.D. |
President, Chief Executive Officer and Director |
美元 621.58K |
29/04/2025 |
| Mr. Thad Allen Huston |
Chief Financial Officer and Principal Accounting Officer |
-- |
24/02/2026 |
| Dr. Subhashis Banerjee, M.D. |
Chief Medical Officer |
-- |
29/04/2025 |
| Mr. Christopher Horan |
Chief Technical Operations Officer |
-- |
29/04/2025 |
| Ms. Jennifer Kinsbruner Bush |
Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer |
美元 478.19K |
29/04/2025 |
| Ms. Neha Krishnamohan |
Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer |
美元 340.88K |
29/04/2025 |
|
|
| Dr. Fred Aslan, M.D. |
President, Chief Executive Officer and Director |
29/04/2025 |
| Ms. Elizabeth L. Hougen |
Independent Director |
29/04/2025 |
| Dr. Alison Moore, PhD |
Director |
29/04/2025 |
| Ms. Elaine K. Sorg |
Director |
19/02/2026 |
| Dr. Diego Miralles, M.D. |
Director |
29/04/2025 |
| Mr. Yong-Jun Huh |
Director |
29/04/2025 |
| Dr. Brian Daniels,M.D. |
Chairman of the Board |
29/04/2025 |
| Dr. Laura Bessen, M.D. |
Independent Director |
29/04/2025 |
| Dr. Laura Stoppel, PhD |
Independent Director |
29/04/2025 |
| Dr. Daniel G. Baker, PhD |
Director |
29/01/2025 |
|
|
|
|
